<DOC>
	<DOCNO>NCT00213746</DOCNO>
	<brief_summary>Viability assessment remain clinical challenge patient coronary artery disease leave ventricular dysfunction . Several image modality available evaluate myocardial viability , base either perfusion contractile reserve analysis . Briefly , perfusion analysis highly sensitive contractile reserve highly specific . A combined analysis perfusion contractile reserve propose improve diagnostic accuracy patient refer revascularization procedure . However , value combine analysis validate unselected patient refer viability assessment . The patient enrol study undergo nitrate enhance rest gate SPECT use Tc-99m labeled tracer ( sestamibi tetrofosmine ) follow second gated SPECT acquire low-dose dobutamine infusion ( 10 mcg/kg/mn ) . All patient 6-month clinical image follow-up , include physical examination nitrate enhance rest gate SPECT use radiopharmaceutical . All treatment receive 6-month period record , include medical therapy coronary revascularization ( angioplasty , stenting CABG ) . Finally , value baseline perfusion contractile reserve analysis predicting leave ventricular ejection fraction change 6-month follow-up evaluate .</brief_summary>
	<brief_title>Evaluation Myocardial Viability Means Low-dose Dobutamine Gated SPECT ( DOGS Study )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Myocardial Stunning</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Documented coronary artery disease Left ventricular dysfunction ( LVEF &lt; 50 % ) Patients refer Nuclear Medicine department myocardial viability assessment Sinus Rhythm Acceptance 6month followup Signed informed consent Recent acute coronary syndrome ( &lt; 21 day ) Atrial Fibrillation significant arrhythmia Implanted pacemaker Contra indication dobutamine Non ischaemic cardiomyopathy Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Coronary Arteriosclerosis</keyword>
	<keyword>Heart Failure , Congestive</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Myocardial Revascularization</keyword>
	<keyword>Tomography , Emission-Computed , Single-Photon</keyword>
	<keyword>Dobutamine</keyword>
	<keyword>Myocardial Stunning</keyword>
	<keyword>Myocardial Hibernation</keyword>
</DOC>